Breaking News Instant updates and real-time market news.

ASPU

Aspen Group

$7.20

0.22 (3.15%)

, AXGN

AxoGen

$18.35

0.1 (0.55%)

08:06
09/13/17
09/13
08:06
09/13/17
08:06

Lake Street to hold a conference

2017 Best Ideas Growth (BIG) Conference is being held in New York on September 13.

ASPU

Aspen Group

$7.20

0.22 (3.15%)

AXGN

AxoGen

$18.35

0.1 (0.55%)

BEAT

BioTelemetry

$37.85

-0.1 (-0.26%)

BIOS

BioScrip

$2.80

0.02 (0.72%)

CRY

CryoLife

$22.80

0.4 (1.79%)

CYBE

Cyberoptics

$15.70

0.05 (0.32%)

DSPG

DSP Group

$12.10

0.25 (2.11%)

ESIO

Electro Scientific

$12.37

0.05 (0.41%)

GAIA

Gaia

$11.45

-0.15 (-1.29%)

NVEE

NV5 Global

$47.95

0.3 (0.63%)

ORBK

Orbotech

$41.93

0.14 (0.34%)

PCTI

PCTEL

$6.13

-0.02 (-0.33%)

PETX

Aratana Therapeutics

$5.95

-0.09 (-1.49%)

PRMW

Primo Water

$11.75

-0.28 (-2.33%)

NLS

Nautilus

$16.55

-0.05 (-0.30%)

TRUP

Trupanion

$22.33

-0.2 (-0.89%)

WIFI

Boingo Wireless

$20.86

-0.05 (-0.24%)

SIEN

Sientra

$12.58

0.12 (0.96%)

  • 13

    Sep

  • 13

    Sep

  • 14

    Sep

  • 14

    Sep

  • 19

    Sep

  • 19

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 28

    Sep

  • 30

    Nov

ASPU Aspen Group
$7.20

0.22 (3.15%)

AXGN AxoGen
$18.35

0.1 (0.55%)

06/29/17
CANT
06/29/17
INITIATION
Target $18
CANT
Overweight
AxoGen initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Travis Steed started AxoGen with an Overweight rating and $18 price target.
03/06/17
ROTH
03/06/17
INITIATION
Target $14.5
ROTH
Buy
AxoGen initiated with a Buy at Roth Capital
Roth Capital analyst Chris Lewis started AxoGen with a Buy rating and $14.50 price target as he believes it is well-positioned to continue expanding the treatment algorithms of surgeons to include all of its products across its full treatment continuum in peripheral nerve repair.
07/31/17
LEER
07/31/17
INITIATION
Target $22
LEER
Outperform
AxoGen initiated with an Outperform at Leerink
Leerink analyst Richard Newitter started AxoGen with an Outperform rating and $22 price target. The company is well positioned to sustain a leading position in peripheral nerve repair, the analyst contends.
07/31/17
07/31/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hostess Brands (TWNK) initiated with a Neutral at UBS. 2. Criteo (CRTO) coverage resumed with an Overweight at KeyBanc. 3. CMS Energy (CMS) initiated with an Equal Weight at Morgan Stanley. 4. AxoGen (AXGN) initiated with an Outperform at Leerink. 5. Covanta (CVA) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
BEAT BioTelemetry
$37.85

-0.1 (-0.26%)

09/13/16
SIDC
09/13/16
INITIATION
Target $27
SIDC
Buy
BioTelemetry initiated with a Buy at Sidoti
Sidoti analyst Mitra Ramgopal initiated Bio Telemtry with a Buy and a $27 price target.
12/02/16
DOTC
12/02/16
INITIATION
Target $26
DOTC
Buy
BioTelemetry initiated with a Buy at Dougherty
Dougherty analyst Gene Mannheimer initiated BioTelemetry with a Buy and a $26 price target.
07/14/17
LSCM
07/14/17
NO CHANGE
Target $50
LSCM
Buy
BioTelemetry price target raised to $50 from $35 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for BioTelemetry to $50 saying the recently closed LifeWatch acquisition should drive profitable growth and position the arrhythmia monitoring platform for expansion. The analyst believes investors should buy the stock now, before the Q2 results. He reiterates a Buy rating on the name.
BIOS BioScrip
$2.80

0.02 (0.72%)

08/10/17
RHCO
08/10/17
UPGRADE
RHCO
Buy
BioScrip upgraded on multiple catalysts at SunTrust
As noted earlier, SunTrust upgraded BioScrip to Buy from Hold. As reasons for the upgrade, analyst David MacDonald cited "ongoing operational improvements, ramping collection/cash flow, solid conviction in new management's ability to execute and recent changes to the capital structure that removed an overhang." He also noted that the company's Q2 EBITDA and cash flow beat expectations, and he says that it could benefit from rate relief created by the Cure Act. Target to $3.75 from $3.25.
06/30/17
CHLM
06/30/17
NO CHANGE
Target $3.5
CHLM
Buy
BioScrip refinancing a positive despite 'unexpected' dilution, says Craig-Hallum
Craig-Hallum analyst Kevin Ellich noted that BioScrip's debt refinancing deal included a private placement of shares and in-the-money warrants, which was "was unexpected and disappointing." However, he views the refinancing as an incremental positive as it extends debt maturities and gives management more time to focus on their turnaround efforts. Ellich keeps a Buy rating on BioScrip shares and raised his price target to $3.50 from $2.50.
08/10/17
RHCO
08/10/17
UPGRADE
RHCO
Buy
BioScrip upgraded to Buy from Hold at SunTrust
06/26/17
BRRR
06/26/17
NO CHANGE
Target $3.5
BRRR
Outperform
BioScrip price target raised to $3.50 from $2 at Barrington
Barrington analyst Michael Petusky raised his price target for BioScrip to $3.50 citing increased conviction in the company's long-term potential following a non-deal roadshow. The analyst has a favorable view of new management and keeps an Outperform rating on the shares.
CRY CryoLife
$22.80

0.4 (1.79%)

07/26/17
ADAM
07/26/17
NO CHANGE
Target $25
ADAM
Buy
CryoLife foundation suggests opportunity for growth, says Canaccord
Canaccord analyst Jason Mills recommended investors build positions in CryoLife on the heels of solid Q2 results. The analyst noted its better than expected top and bottom line results and said its strong foundation portends a huge opportunity for growth via both its internal pipeline and M&A. Mills reiterated his Buy rating and raised his price target to $25 from $23.50 on CryoLife shares.
02/17/17
LTCO
02/17/17
UPGRADE
Target $20
LTCO
Buy
CryoLife upgraded to Buy from Neutral at Ladenburg
Ladenburg Thalmann analyst Jeffrey Cohen upgraded CryoLife to Buy following the company's Q4 results. On-X aortic and mitral prosthetic valves are currently very well positioned for growth, the analyst contends. He raised his price target for the shares to $20 from $15.
CYBE Cyberoptics
$15.70

0.05 (0.32%)

04/07/17
CHLM
04/07/17
INITIATION
Target $35
CHLM
Buy
Cyberoptics initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Greg Palm started Cyberoptics with a Buy rating and a $35 price target as he believes its new product portfolio can double revenue and quadruple earnings over the next 4-5 years.
08/23/17
CHLM
08/23/17
NO CHANGE
Target $25
CHLM
Buy
Cyberoptics price target lowered to $25 from $30 at Craig-Hallum
Craig-Hallum analyst Greg Palm lowered his price target for Cyberoptics to $25 from $30 following the recent post-earnings selloff. While the analyst says the selloff is understandable given the company's two negative earnings revisions this year, the inherent value of its product portfolio and technology is becoming too hard to ignore. He reiterates a Buy rating on the shares.
04/26/17
CHLM
04/26/17
NO CHANGE
Target $35
CHLM
Buy
The worst is behind Cyberoptics, says Craig-Hallum
Craig-Hallum analyst Greg Palm believes that underlying demand and pipeline activity suggest Cyberoptics remains in the early innings of a "significant transformation and growth opportunity." While shares remain well below previous highs, the analyst believes this offers an attractive entry point and sees a lot to be excited about. Palm reiterates a Buy rating and $35 price target on the shares, and says the worst is behind the company.
DSPG DSP Group
$12.10

0.25 (2.11%)

09/04/17
09/04/17
NO CHANGE

Libre Wireless using DSP Group SmartVoice technology
DSP Group announced that Libre Wireless Technologies is using DSP Group's SmartVoice technology for its industry leading fully integrated LS5BV LibreSync voice and media streaming module. The LS5BV module includes DSP Group's HDClear SoC with sophisticated algorithms for detecting and processing far field voice, including advanced noise reduction, echo cancellation, music barge-in and audio processing features. It is designed to support from 1 to 3 mics, giving customers flexibility for various applications that can be optimized for cost, front facing 180 or circular 360 degree applications. The LS5BV offers a clean interface to off-module mics allowing the product designer ultimate flexibility on mic placement and product integration while providing a simple low cost interface in a fully integrated mic-to-cloud voice solution. DSP Group's HDClear SoC is an innovative audio/voice SoC for IoT devices as smart speakers which enables far-field device activation and operation via voice commands while maintaining low power consumption and high performance using pre-process algorithms such as noise reduction, beam-forming and Acoustic Echo Canceling for barge-in mode using 1 to 3 mics.
04/25/17
WDLK
04/25/17
DOWNGRADE
WDLK
Hold
DSP Group downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Matthew Robison downgraded DSP Group to Hold.
04/25/17
WDLK
04/25/17
DOWNGRADE
Target $13
WDLK
Hold
DSP Group downgraded to Hold ahead of earnings at Wunderlich
Wunderlich analyst Matthew Robison downgraded DSP Group to Hold from Buy citing valuation with the shares up more than 20% from the close of trading on February 2. The analyst sees "insufficient opportunity for appreciation" relative to his new price target of $13, which is raised from $12. DSP reports results on April 27.
04/25/17
BNCH
04/25/17
INITIATION
BNCH
Hold
DSP Group initiated with a Hold at Benchmark
Benchmark analyst Scott Searle initiated DSP Group with a Hold saying 2017 remains a transition year.
ESIO Electro Scientific
$12.37

0.05 (0.41%)

08/03/17
08/03/17
UPGRADE
Target $12

Buy
Electro Scientific upgraded to Buy at Needham
As previously reported, Needham analyst James Ricchiuti upgraded Electro Scientific to Buy from Hold, with a $12 price target, after the company reported much better than expected Q1 results, highlighted by another "outstanding" bookings quarter.
02/27/17
LSCM
02/27/17
INITIATION
Target $7.5
LSCM
Buy
Electro Scientific initiated with a Buy at Lake Street
Lake Street analyst Jaeson Schmidt started Electro Scientific with a Buy rating and $7.50 price target.
08/03/17
NEED
08/03/17
UPGRADE
NEED
Buy
Electro Scientific upgraded to Buy from Hold at Needham
02/27/17
02/27/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Laureate Education (LAUR) initiated with a Buy at Stifel, with an Outperform at Macquarie, with an Overweight at Morgan Stanley, with an Overweight at Piper Jaffray and with an Equal Weight at Barclays. 2. Invitation Homes (INVH) initiated with a Buy at BofA Merrill Lynch, with a Buy at Deutsche Bank, with an Outperform at Credit Suisse, with an Overweight at JPMorgan, with an Overweight at Morgan Stanley and with a Neutral at Goldman Sachs. 3. Electro Scientific (ESIO) initiated with a Buy at Lake Street. 4. Heron Therapeutics (HRTX) initiated with a Buy at Needham. 5. American Homes 4 Rent (AMH) initiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GAIA Gaia
$11.45

-0.15 (-1.29%)

NVEE NV5 Global
$47.95

0.3 (0.63%)

04/11/17
ROTH
04/11/17
NO CHANGE
Target $43
ROTH
Buy
Transportation funding bill provides tailwind for NV5 Global, says Roth Capital
Roth Capital analyst Jeff Martin notes that the California legislature passed SB-1, a transportation spending bill that funds a $52B budget spanning 10 years, primarily for the state highway system and local streets and road system. With California as a key market for NV5 Global, the analyst believes the funding bill provides a tailwind for organic growth for the company. He reiterates a Buy rating and $43 price target on the shares.
12/02/16
ROTH
12/02/16
NO CHANGE
Target $37
ROTH
Buy
Roth Capital positive on NV5 Global acquisition of The Hanna Group
Roth Capital analyst Jeff Martin says the acquisition of The Hanna Group strengthens NV5 Global's infrastructure presence in California, and notes that the former's capabilities in program management are additive to the latter. The analyst believes The Hanna Group has significant growth potential, both from the project pipeline as well as increased capacity with the resource capability of NV5 Global, in addition to the potential to expand the business into southern California. He reiterates a Buy rating and $37 price target on NV5 Global's shares.
12/08/16
ROTH
12/08/16
NO CHANGE
Target $43
ROTH
Buy
NV5 Global price target raised to $43 from $37 at Roth Capital
Roth Capital analyst Jeff Martin raised his price target to $43 from $37 to reflect the Hanna Group and CivilSource acquisitions. The analyst reiterates a Buy rating on the shares.
07/05/17
SIDC
07/05/17
INITIATION
Target $45
SIDC
Neutral
NV5 Global initiated with a Neutral at Sidoti
Sidoti analyst Tate Sullivan initiated NV5 Global with a Neutral and a $45 price target.
ORBK Orbotech
$41.93

0.14 (0.34%)

08/31/17
STFL
08/31/17
INITIATION
Target $46
STFL
Buy
Orbotech initiated with a Buy at Stifel
Stifel analyst Patrick Ho started Orbotech with a Buy rating and $46 price target saying the company has a diversified product portfolio with "multiple" growth drivers.
05/22/17
STPT
05/22/17
DOWNGRADE
STPT
Hold
Orbotech downgraded to Hold from Buy at Standpoint Research
03/08/17
STPT
03/08/17
UPGRADE
STPT
Buy
Orbotech upgraded to Buy from Hold at Standpoint Research
05/23/17
OPCO
05/23/17
NO CHANGE
Target $42
OPCO
Outperform
Oppenheimer keeps Outperform rating on Orbotech 'for now'
Oppenheimer analyst Andrew Uerkwitz says that "for now," he's keeping his Outperform rating on $42 price target on Orbotech given the lack of visibility into the final outcome of the Israel Tax Authority's investigation. More often than not, ITA audits do not end up in criminal investigations, the analyst tells investors in a research note.
PCTI PCTEL
$6.13

-0.02 (-0.33%)

04/12/17
LSCM
04/12/17
INITIATION
Target $8
LSCM
Buy
PCTEL initiated with a Buy at Lake Street
Lake Street analyst Jaeson Schmidt started PCTEL with a Buy rating and $8 price target. The analyst sees an attractive risk/reward opportunity with the antenna business growing and the RF Solutions segment stable.
05/10/17
WDLK
05/10/17
DOWNGRADE
Target $8
WDLK
Hold
PCTEL downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Matthew Robison downgraded PCTEL to Hold saying the RF Solution is correcting slower than expected, resulting in a reduction in his price target to $8 from $8.50, and views valuation as full.
PETX Aratana Therapeutics
$5.95

-0.09 (-1.49%)

04/13/17
JEFF
04/13/17
NO CHANGE
Target $8
JEFF
Buy
Zoetis deal for Nexvet suggests $9 per share value for Aratana, says Jefferies
After Zoetis (ZTS) announced a deal to buy Nexvet Biopharma for $85M, Jefferies analyst David Gu said the multiple for the deal would suggest a $9 per share valuation for Aratana Therapeutics (PETX), which is also innovative companion animal biotech company. The analyst, who thinks Aratana's Entyce and Nocita would complement the portfolios of an acquirer, keeps a Buy rating and $8 price target on Aratana shares.
02/06/17
STFL
02/06/17
DOWNGRADE
STFL
Hold
Aratana Therapeutics downgraded to Hold from Buy at Stifel
PRMW Primo Water
$11.75

-0.28 (-2.33%)

08/03/17
BRRR
08/03/17
DOWNGRADE
BRRR
Underperform
PharMerica downgraded to Underperform from Outperform at Barrington
Barrington analyst Michael Petusky double downgraded PharMerica (PMC) to Underperform saying other takeover bidders are unlikely to emerge. The analyst suggests redeploying proceeds into Tivity Health (TVTY), Primo Water (PRMW), U.S. Physical Therapy (USPH) and OPKO Health (OPK).
01/09/17
BRRR
01/09/17
NO CHANGE
BRRR
Barrington lays out best stock ideas for 2017
Student Transportation Analysts at Barrington Research laid out their best stock ideas for 2017. In the alphabetical order, the firm's top picks are Chegg (CHGG), Cinemark (CNK), DeVry (DV), Echo Global (ECHO), Gray Television (GTN), Hackett Group (HCKT), Healthways (HWAY), Heritage-Crystal Clean (HCCI), Kadant (KAI), Koppers Holdings (KOP), Primo Water (PRMW), Student Transportation (STB) and WNS Holdings (WNS).
04/03/17
BMOC
04/03/17
INITIATION
BMOC
Market Perform
Primo Water initiated with a Market Perform at BMO Capital
BMO Capital analyst Amit Sharma,expects Primo to benefit from strong demand for water and concerns about tap water quality. However, he expects the stock to rise only modestly from current levels, and "would be more constructive on a pullback and/or a possible recurrence of tap water quality issues." Target $15.
NLS Nautilus
$16.55

-0.05 (-0.30%)

08/09/17
DADA
08/09/17
UPGRADE
Target $22
DADA
Buy
Nautilus upgraded to Buy from Neutral at DA Davidson
DA Davidson analyst Andrew Burns upgraded Nautilus to Buy and raised his price target for the shares to $22 from $19. The post-earnings selloff has created an attractive entry point, Burns tells investors in a research note. He expects the company's headwinds to dissipate going forward.
08/02/17
IMPC
08/02/17
NO CHANGE
Target $20
IMPC
Outperform
Nautilus risk/reward compelling after Q2 results, says Imperial Capital
Imperial Capital analyst George Kelly believes Nautilus shares offer a "compelling" risk/reward following the post-earnings selloff. Management's 2017 guidance is achievable given the trends in Treadclimber, Max Trainer, and the retail segment, Kelly tells investors in a research note. He lowered his price target for the shares to $20 from $21 and keeps an Outperform rating on the name.
09/11/17
AGIS
09/11/17
INITIATION
Target $21
AGIS
Buy
Nautilus initiated with a Buy at Aegis
Aegis analyst Rommel Dionisio initiated Nautilus with a Buy and a $21 price target and views the recent selloff in shares as an attractive buying opportunity. The analyst said Nautilus has a strong track record of double digit organic growth and operating margin expansion driven by new product introductions and initial penetration into overseas markets.
09/05/17
RILY
09/05/17
UPGRADE
Target $22
RILY
Buy
Nautilus resumed with a Buy from Neutral at B. Riley
B. Riley analyst Eric Wold resumed coverage of Nautilus with a Buy rating and $22 price target, an upgrade from his previous Neutral rating and $18.50 price target when coverage was suspended earlier this year. The analyst sees "solid initial demand trends" for Bowflex HVT and notes the company's comparisons get easier in the second half of 2017.
TRUP Trupanion
$22.33

-0.2 (-0.89%)

WIFI Boingo Wireless
$20.86

-0.05 (-0.24%)

03/08/17
OPCO
03/08/17
NO CHANGE
Target $15
OPCO
Outperform
Oppenheimer sees Boingo Wireless as 'undervalued,' likely takeover target
Oppenheimer analyst Timothy Horan believes Boingo Wireless has "successfully transitioned" its business model to become a wholesale shared infrastructure company, enabling connectivity in densely populated areas. The analyst continues to see Boingo Wireless as a "unique" shared wireless spectrum/infrastructure company that is "undervalued" and a likely takeover target. He reiterates an Outperform rating and $15 price target.
12/14/16
OPCO
12/14/16
UPGRADE
OPCO
Outperform
Akamai upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Timothy Horan upgraded Akamai (AKAM) to Outperform saying the Trump administration and Republican-led Congress should be very positive for the Communication and Cloud sector. Lower taxes, less regulation, incentives to spend on infrastructure and "what could be a unique time to roll out disruptive services and consolidate should be very positive for our sector," Horan tells investors in a research note. He has an $80 price target for Akamai shares. The analyst also raised his price target for Microsoft to $70 from $65 and for Boingo Wireless (WIFI) to $15 from $12. Both of the stocks remain Outperform rated.
04/25/17
BNCH
04/25/17
INITIATION
Target $18
BNCH
Buy
Boingo Wireless initiated with a Buy at Benchmark
Benchmark analyst Scott Searle initiated Boingo Wireless with a Buy rating and $18 price target.
03/10/17
OPCO
03/10/17
NO CHANGE
OPCO
CenturyLink, GTT Communications offer buying opportunities, says Oppenheimer
Oppenheimer analyst Timothy Horan sees an opportunity in CenturyLink (CTL), GTT Communications (GTT) and Boingo Wireless (WIFI) post earnings given what he views as "fundamental dislocations" in stock prices. For CenturyLink, the analyst remains confident in the Level 3 (LVLT) closing and in the sustainability of the dividend afterwards. Horan continues to be a buyer of these names on weakness.
SIEN Sientra
$12.58

0.12 (0.96%)

08/28/17
ADAM
08/28/17
INITIATION
Target $14
ADAM
Buy
Sientra initiated with a Buy at Canaccord
Canaccord analyst Kyle Rose initiated Sientra with a Buy rating and $14 price target. The analyst sees Sientra as uniquely positioned to take market share across multiple segments of the U.S. aesthetics industry and for that share to be supported by Sientra's broader product portfolio that includes a focus on breast reconstruction, scar reduction, and the energy-based capital device market.
09/13/17
WBLR
09/13/17
UPGRADE
WBLR
Outperform
Sientra upgraded to Outperform from Market Perform at William Blair
William Blair analyst Margaret Kaczor upgraded Sientra to Outperform saying the manufacturing approval is "just the tip of the story."
07/11/17
SPHN
07/11/17
INITIATION
Target $12
SPHN
Overweight
Sientra initiated with an Overweight at Stephens
Stephens initiated Sientra with an Overweight rating and $12 price target.
04/17/17
04/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. ProPetro Holding (PUMP) initiated with a Buy at Tudor Pickering. 2. Canadian Solar (CSIQ) initiated with a Buy at Axiom. 3. Bright Horizons (BFAM) assumed with an Outperform at Credit Suisse. 4. Sientra (SIEN) initiated with a Buy at Lake Street. 5. Himax (HIMX) initiated with an Outperform at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

HPE

HP Enterprise

$13.79

0.16 (1.17%)

18:47
09/21/17
09/21
18:47
09/21/17
18:47
Periodicals
HP Enterprise planning approximately 5,000 job cuts, Bloomberg reports »

In part of a broader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

RP

RealPage

$39.35

-0.1 (-0.25%)

18:41
09/21/17
09/21
18:41
09/21/17
18:41
Hot Stocks
RealPage expects $3M-$4M of renter's insurance claims from hurricanes »

RealPage announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$13.79

0.16 (1.17%)

18:39
09/21/17
09/21
18:39
09/21/17
18:39
Periodicals
Breaking Periodicals news story on HP Enterprise »

HP Enterprise planning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

YUM

Yum! Brands

$76.48

0.11 (0.14%)

18:37
09/21/17
09/21
18:37
09/21/17
18:37
Conference/Events
Yum! Brands management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MAR

Marriott

$107.57

-0.12 (-0.11%)

18:32
09/21/17
09/21
18:32
09/21/17
18:32
Conference/Events
Marriott management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

ESPGY

Esprit Holdings

$1.21

0.018 (1.51%)

18:29
09/21/17
09/21
18:29
09/21/17
18:29
Conference/Events
Esprit Holdings management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BA

Boeing

$256.04

0.58 (0.23%)

18:18
09/21/17
09/21
18:18
09/21/17
18:18
Hot Stocks
Boeing: Turkish Airlines announces intent to order 40 787-9 Dreamliners »

Boeing and Turkish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

M

Macy's

$21.16

-0.32 (-1.49%)

18:18
09/21/17
09/21
18:18
09/21/17
18:18
Conference/Events
Macy's management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

TAHO

Tahoe Resources

$5.60

0.02 (0.36%)

18:12
09/21/17
09/21
18:12
09/21/17
18:12
Hot Stocks
Tahoe Resources raises 2017 gold operations view to 400K-500K »

Tahoe Resources updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATKR

Atkore

$18.42

0.02 (0.11%)

18:11
09/21/17
09/21
18:11
09/21/17
18:11
Conference/Events
Atkore management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

, TXN

Texas Instruments

$86.05

0.22 (0.26%)

18:11
09/21/17
09/21
18:11
09/21/17
18:11
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

TXN

Texas Instruments

$86.05

0.22 (0.26%)

PSDO

Presidio

$13.95

-0.06 (-0.43%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 21

    Sep

FTR

Frontier Communications

$11.69

-0.31 (-2.58%)

18:10
09/21/17
09/21
18:10
09/21/17
18:10
Hot Stocks
Frontier Communications operations in Florida return to near-normal levels »

Daily operations for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLYA

Playa Hotels & Resorts

$10.66

-0.06 (-0.56%)

18:07
09/21/17
09/21
18:07
09/21/17
18:07
Hot Stocks
Playa Hotels & Resorts reports no significant damage from Maria »

Playa Hotels &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

18:07
09/21/17
09/21
18:07
09/21/17
18:07
Hot Stocks
Ascendis spikes higher after Versartis Velocity trial fails to meet endpoint »

Shares of Ascendis Pharma…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$103.90

-0.04 (-0.04%)

18:04
09/21/17
09/21
18:04
09/21/17
18:04
Hot Stocks
Celanese increases price of acetyl intermediates »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNOW

NOW Inc.

$12.98

0.1 (0.78%)

18:03
09/21/17
09/21
18:03
09/21/17
18:03
Conference/Events
NOW Inc. management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 01

    Nov

JOBS

51job

$58.50

0.01 (0.02%)

18:02
09/21/17
09/21
18:02
09/21/17
18:02
Hot Stocks
51job announces strategic investment in Lagou »

51job announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$43.63

0.17 (0.39%)

17:53
09/21/17
09/21
17:53
09/21/17
17:53
Conference/Events
Hess Corp. management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

APC

Anadarko

$48.49

3.68 (8.21%)

17:43
09/21/17
09/21
17:43
09/21/17
17:43
Recommendations
Anadarko analyst commentary  »

Anadarko buyback a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

HCC

Warrior Met Coal

$23.28

-1.05 (-4.32%)

17:42
09/21/17
09/21
17:42
09/21/17
17:42
Hot Stocks
Warrior Met Coal receives favorable IRS private letter ruling »

Warrior Met Coal reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAA

MAA

$107.27

-0.03 (-0.03%)

17:35
09/21/17
09/21
17:35
09/21/17
17:35
Hot Stocks
MAA announces estimated impact of Hurricanes Irma and Harvey »

MAA announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$280.42

0.38 (0.14%)

17:31
09/21/17
09/21
17:31
09/21/17
17:31
Hot Stocks
Northrop Grumman awarded $124.7M government contract »

Northrop Grumman Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$205.72

1.45 (0.71%)

17:29
09/21/17
09/21
17:29
09/21/17
17:29
Hot Stocks
General Dynamics Electric Boat awarded $5B government contract »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAN

Aaron's

$38.83

-0.39 (-0.99%)

17:19
09/21/17
09/21
17:19
09/21/17
17:19
Hot Stocks
Aaron's provides update on impact of Hurricane Irma »

Aaron's plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDC

M.D.C. Holdings

$31.73

0.11 (0.35%)

17:10
09/21/17
09/21
17:10
09/21/17
17:10
Hot Stocks
M.D.C. Holdings announces Richmond American Homes enters Oregon Market »

M.D.C. Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.